Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 24, 2026Breast CancerOpen Access

Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial

View Full Paper
Ask AI
Bookmark
Share

Authors

TYTakashi YamanakaJSJ K SohnKSKazuki Sudo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yamanaka et al. (2026) studied this question.

synapsesocial.com/papers/6aa31b62f5dd0cd6dfcdeb07https://doi.org/10.1007/s12282-026-01865-0
View Full Paper
Ask AI
Bookmark
Share